Intellectual Property India Publishes Patent Application for 'Monoclonal Antibodies Against Nipah Virus' Filed by Translational Health Science And Technology Institute; and Rajiv Gandhi Centre For Biotechnology

MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202517077883 A) filed by Translational Health Science And Technology Institute; and Rajiv Gandhi Centre For Biotechnology, Faridabad, Haryana, on Aug. 15, 2025, for 'monoclonal antibodies against nipah virus.'

Inventor(s) include Bhattacharya, Jayanta; Deshpande, Suprit; Shrivas, Shweta; and Kumar, Naresh.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to an engineered monoclonal antibody having fragments of heavy chain (HC) and light chain (LC) selected from SEQ ID No. 1, 2, 3, 4, 5, 6, 7, 8, 9 10, 11, 12, 13, 14 a...